Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a randomized, clinical phase I/II treatment trial studying Lacticaseibacillus rhamnosus GG (LGG) or placebo or no treatment in patients with gastrointestinal, abdominal, or pelvic cancer under Chemoradiotherapy (CRT)
Comparing the proportion of patients receiving abdominal or pelvic chemoradiation with a fluoropyrimidine being treated with the probiotic LGG who develop CTCAE grade 2 or greater diarrhea to the proportion of patients receiving abdominal or pelvic chemoradiation with a fluoropyrimidine being treated with placebo who develop CTCAE grade 2 or greater diarrhea, safety
No published results were found as of March 2026
…